These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 32448271)

  • 21. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
    Guo J; Li X; Shen S; Wu X
    Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer.
    Jiang H; Gu J; Du J; Qi X; Qian C; Fei B
    Mol Med Rep; 2020 Jan; 21(1):347-359. PubMed ID: 31939629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ferroptosis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
    Lei T; Qian H; Lei P; Hu Y
    Cancer Sci; 2021 Nov; 112(11):4785-4798. PubMed ID: 34506683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatics analysis and validation of mesenchymal stem cells related gene MT1G in osteosarcoma.
    Zheng S; Cheng X; Ke S; Zhang L; Wu H; He D; Cheng X
    Aging (Albany NY); 2024 May; 16(9):8155-8170. PubMed ID: 38747739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of TNFRSF1A as a potential biomarker for osteosarcoma.
    Zhang Y; Liu K; Wang J
    Cancer Biomark; 2024; 39(4):299-312. PubMed ID: 38250759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures.
    Tian W; Li Y; Zhang J; Li J; Gao J
    Gene; 2018 Apr; 650():7-14. PubMed ID: 29407229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a pro-protein synthesis osteosarcoma subtype for predicting prognosis and treatment.
    Yi C; Liu J; Zhao S; Gong D; Xu B; Li A; Bian E; Tian D
    Sci Rep; 2024 Jul; 14(1):16475. PubMed ID: 39014082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive investigation of tumor immune microenvironment and prognostic biomarkers in osteosarcoma through integrated bulk and single-cell transcriptomic analysis.
    Shi S; Zhang L; Guo X
    Front Immunol; 2024; 15():1424950. PubMed ID: 39108264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and Validation of a Potent Multi-miRNA Signature for Prediction of Prognosis of Osteosarcoma Patients.
    Luo X; Tang J; Xuan H; Liu J; Li X
    Med Sci Monit; 2020 Feb; 26():e919272. PubMed ID: 32098942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and experimental validation of hypoxia-related gene signatures for osteosarcoma diagnosis and prognosis based on WGCNA and machine learning.
    Wen B; Chen J; Ding T; Mao Z; Jin R; Wang Y; Shi M; Zhao L; Yang A; Qin X; Chen X
    Sci Rep; 2024 Aug; 14(1):18734. PubMed ID: 39134603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Differentially Expressed Genes under the Regulation of Transcription Factors in Osteosarcoma.
    Liu Y; Guan J; Chen X
    Pathol Oncol Res; 2019 Jul; 25(3):1091-1102. PubMed ID: 30411296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nomograms for predicting overall survival and cancer-specific survival of chondroblastic osteosarcoma patients.
    Gao Z; Zhou S; Song H; Wang Y; He X
    J Surg Oncol; 2020 Dec; 122(8):1676-1684. PubMed ID: 32862456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A five-immune-related genes-based prognostic signature for colorectal cancer.
    Zhu L; Wang H; Wang Z
    Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.
    Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ
    Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
    He L; Yang H; Huang J
    BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma.
    Chen J; Guo X; Zeng G; Liu J; Zhao B
    Comput Math Methods Med; 2020; 2020():8081973. PubMed ID: 33082842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling.
    Fan H; Lu S; Wang S; Zhang S
    Mol Med Rep; 2019 Aug; 20(2):915-930. PubMed ID: 31173206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
    Xie L; Zeng J; He M
    BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a five-microRNA signature as a prognostic biomarker for esophageal squamous cell carcinoma.
    Yu J; Zhu M; Lv M; Wu X; Zhang X; Zhang Y; Li J; Zhang Q
    Sci Rep; 2019 Dec; 9(1):19847. PubMed ID: 31882677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.